# Effect on Blood Chemistry and Inflammatory Marker of Omega-3 Enriched Total Parenteral Nutrition

> **NCT02468713** · PHASE4 · COMPLETED · sponsor: **Chonbuk National University Hospital** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Combiflex® lipid peri
- **DRUG:** Winuf® peri

## Key facts

- **NCT ID:** NCT02468713
- **Lead sponsor:** Chonbuk National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2015-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02468713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02468713, "Effect on Blood Chemistry and Inflammatory Marker of Omega-3 Enriched Total Parenteral Nutrition". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02468713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*